Studies have shown that inhibition of the process of DNA damage repair, such as inhibitors of kinase WEE1, could effectively prevent the progress of DLBCL (Knittel et al., 2018; Jong et al., 2020). This evidence concerns the gene WEE1 and diffuse large B-cell lymphoma.